Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy

Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy

REP 2139 is a nucleic acid polymer (NAP) currently under clinical development for chronic hepatitis B (HBV) therapy. This preclinical study investigated different REP 2139 analogs that would display reduced accumulation in the serum and tissues, while retaining an antiviral effect against HBV infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Ingo Roehl (Author), Stephan Seiffert (Author), Celia Brikh (Author), Jonathan Quinet (Author), Catherine Jamard (Author), Nadine Dorfler (Author), Jennifer A. Lockridge (Author), Lucyna Cova (Author), Andrew Vaillant (Author)
Format: Book
Published: Elsevier, 2017-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items